Showing results (161-170 of 253) with videos related to
Sort By:
Pageof 26
Circulation|August 11, 2004
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathyDick de Zeeuw, Giuseppe Remuzzi, Hans-Henrik Parving, et al.Kidney International|May 20, 2004
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAALDick de Zeeuw, Giuseppe Remuzzi, Hans-Henrik Parving, et al.Diabetes Care|July 28, 2004
Cost-effectiveness of early irbesartan treatment versus control (standard antihypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and dihydropyridine calcium channel blockers) or late irbesartan treatment in patients with type 2 diabetes, hypertension, and renal diseaseAndrew J Palmer, Lieven Annemans, Stéphane Roze, et al.Kidney International. Supplement|December 23, 2004
Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuriaAndrew J Palmer, Lieven Annemans, Stéphane Roze, et al.The Lancet. Diabetes & Endocrinology|May 6, 2014
Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trialUlrik Pedersen-Bjergaard, Peter Lommer Kristensen, Henning Beck-Nielsen, et al.Nephron. Clinical Practice|January 22, 2011
Endothelial progenitor cells in long-standing asymptomatic type 1 diabetic patients with or without diabetic nephropathyHenrik Reinhard, Peter Karl Jacobsen, Maria Lajer, et al.Cardiovascular Diabetology|August 2, 2011
Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuriaHenrik Reinhard, Mads Nybo, Peter R Hansen, et al.Cardiovascular Diabetology|May 21, 2015
Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetesBernt Johan von Scholten, Henrik Reinhard, Tine Willum Hansen, et al.Diabetes Care|July 27, 2005
Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathySofia B Ahmed, Peter Hovind, Hans-Henrik Parving, et al.Journal of the American Society of Nephrology : JASN|January 18, 2008
ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathyHans-Henrik Parving, Dick de Zeeuw, Mark E Cooper, et al.Pageof 26